Clinical Trials Logo

Hyperglycemia clinical trials

View clinical trials related to Hyperglycemia.

Filter by:

NCT ID: NCT01804738 Completed - Hyperglycemia Clinical Trials

Investigating Inter-individual Variability in Glycemic and Insulin Responses

Start date: March 2013
Phase: N/A
Study type: Interventional

This study aims to test the following hypothesis in healthy lean young men: - There are differences in glycemic response (GR) and insulin response (IR) between Chinese, Malay and Asian-Indian - There are differences in GI values to the same food between ethnic groups - There are ethnic differences postprandial GR and IR for high vs low GI foods - Mastication, salivary amylase activity, gastric emptying rate and gut microbiota composition influences inter-individual glycemic and insulinemic variability - Ethnic differences in mastication, salivary amylase activity, gastric emptying rate and gut microbiota composition determines the inter-ethnic glycemic and insulinemic variability

NCT ID: NCT01803568 Completed - Hyperglycemia Clinical Trials

Skeletal Muscles, Myokines and Glucose Metabolism MYOGLU

MyoGlu
Start date: September 2011
Phase: N/A
Study type: Interventional

Normal glucose uptake and metabolism in skeletal muscles are essential to keep blood glucose within normal range and hence, insulin resistance (possibly mediated by inflammatory processes) in skeletal muscle is a major pathogenic factor in type 2 diabetes. Physical activity seems to be of essential importance in the prevention and treatment of type 2 diabetes. Myokines are proteins secreted from skeletal muscle that can execute important biological functions locally in the muscle (paracrine) or in other organs like the brain, heart and pancreas (endocrine). Evidence suggest that several interleukines and other cytokines are secreted by skeletal muscles. In the present project, the investigators will explore the relation between secreted myokines from muscle cells, insulin resistance and glucose metabolism before and after 12 weeks of exercise intervention. Subjects with normal as well as impaired glucose metabolism will be included in the study.

NCT ID: NCT01796847 Completed - Critical Illness Clinical Trials

Relationship Between PTEN and Glycemic Variability and Outcome in Critically Ill Patients

GLUPTEN
Start date: December 2012
Phase: N/A
Study type: Observational

Glycemic variability in critically ill patients is a recognized negative prognostic factor. The molecular mechanisms determining inter-patients variability in glucose metabolism during stress are not fully understood. The Phosphatase and Tensin homolog (PTEN) is known to influence glucose homeostasis by interfering in intracellular insulin signaling. Aim of this study is to ascertain whether differential expression of PTEN in critically ill patients correlates with glycemic variability and clinical outcome.

NCT ID: NCT01768429 Completed - Hyperglycemia Clinical Trials

The Effect of n-3 Fatty Acids and Fish on Glucose and Lipid Metabolism in Subjects With Impaired Glucose Metabolism

Start date: October 2012
Phase: N/A
Study type: Interventional

The aim of the project is to examine whether the sources of n-3 fatty acids and fish itself differ in their effects on glucose metabolism, lipid metabolism, blood pressure, and serum inflammatory markers. Lipidomic profiles and gene expression will be used for thorough assessment of the possible clinical changes. The study will compare the effects of alpha-linolenic acid containing vegetable oil, fatty fish, lean fish and control diet. The results of this project will help to identify the optimal source of n-3 fatty acids, and reveal the significance of the components of fish other than fatty acids. These data will be useful both nationally and internationally, since highly controlled dietary interventions utilizing new methodology are scarce.

NCT ID: NCT01763567 Completed - Hyperglycemia Clinical Trials

Feasibility Study to Evaluate Safety and Device Performance of the Hospital Glucose Management System (HGMS)

MAHI
Start date: March 2012
Phase: N/A
Study type: Observational

The purpose of this study is to assess safety and device performance of the Medtronic Hospital Glucose Management System (HGMS) for up to 72-hours.

NCT ID: NCT01720381 Completed - Hyperglycemia Clinical Trials

OptiScanner Versus Standard Blood Glucose Monitoring

Start date: July 2012
Phase: N/A
Study type: Observational

The study is to demonstrate the accuracy of the OptiScanner in measuring blood glucose levels in critically ill patients when compared to a reference YSI 2300 STAT Plus and the Gem 3000, the reference standard for Erasme University Hospital.

NCT ID: NCT01719003 Completed - Clinical trials for Diabetes Mellitus, Type 2

Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes

Start date: October 2012
Phase: Phase 3
Study type: Interventional

This study will investigate the efficacy and safety of two doses (high and low) of empagliflozin in combination with metformin (500 mg and 1000 mg) administered twice daily in patients with type 2 diabetes mellitus (T2DM). Study will compare four dose combinations of empagliflozin + metformin versus each individual component after 24 weeks of treatment.

NCT ID: NCT01684332 Completed - Clinical trials for Hyperglycemia, Postprandial

Postprandial Response to Different Jams

Start date: September 2010
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effects of an acute intake of three different types of strawberry jam, differing in the carbohydrates and antioxidants content, on postprandial glucose metabolism, lipid profile, antioxidant status and satiety indices, in healthy adults.

NCT ID: NCT01680185 Completed - Hyperglycemia Clinical Trials

Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation

SAPT-NODAT
Start date: August 2012
Phase: Phase 3
Study type: Interventional

The SAPT-NODAT study will test the hypotheses that intensive subcutaneous insulin treatment with short acting insulin, applied continuously through an insulin pump, (i) improves glycemic control, (ii) reduces the prevalence of NODAT and prediabetes, and (iii) offers further β-cell protection, in comparison to the standard of care control group, and the basal insulin treatment group. In the SAPT-NODAT study, we will employ sensor-augmented insulin-pump technology, which performs like a semi-closed loop to prevent hypoglycemic events. Patients in the SAPT-NODAT study will be followed through 24 months post-transplantation.

NCT ID: NCT01625442 Completed - Metabolic Syndrome Clinical Trials

Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome

Start date: January 2010
Phase: Phase 4
Study type: Interventional

The metabolic syndrome is associated with increased risk of cardiovascular disease and diabetes mellitus. The age-adjusted prevalence of the metabolic syndrome in the United States is 34% for men and 35% for women. Emerging alternative medicine worldwide led investigators to evaluate the efficacy of Crocus sativus (Saffron) and Berberis Vulgaris (barberry fruit) in treatment of metabolic syndrome. Serum total cholesterol, serum LDL cholesterol, serum HDL cholesterol, serum triglyceride, Fasting Blood Sugar and hematocrit measured before and after 45 days of treatment.